
SOLV · NYSE
Solventum Corporation
$81.05 -8.30 (-9.29%)
Company overview
Solventum Corporation, a healthcare company, engages in developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment provides solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NYSE
- Market cap
- $13.8B
- Employees
- 22,000
- Headquarters
- Maplewood, MN
- Website
- solventum.com
- CEO
- Bryan C. Hanson
- Listed
- April 1, 2024
- P/E
- 9.87
- Dividend yield
- 0.00%
Company financials
- Revenue
- $8.3B
- Gross profit
- $4.4B
- Operating income
- $2.1B
- EBITDA
- $2.8B
- Net income
- $1.4B
- EPS
- $8.21
- Total assets
- $14.1B
- Total debt
- $5.1B
- Gross margin
- 53.67%
- Net margin
- 17.33%
- Earnings yield
- 10.13%
Showing FY 2025
News